Sarissa Capital Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Sarissa Capital Management LP
CRD #167244
SEC #801-77926
CIK #0001577524
AUM $558.6 M (2025-07-31)
Employees 10 (60% Investors, 0% Brokers)
Phone203-302-2330
Address500 West Putnam Avenue
Greenwich, CT 06830
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
1400112084056028002011201620212026
CIK Period
0001577524
Sector Form 13F Holdings Value ($M)
Theravance Inc 56.6
Neurocrine Biosciences Inc 38.1
Amarin Corp PLC UK 20.2
Cytokinetics Inc 19.4
Ironwood Pharmaceuticals Inc 11.4
Lantheus Holdings Inc 7.9
Vor Biopharma Inc 0.8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
Type Form D Funds Date Sold ($M) AUM ($M)
HF ISP Fund LP 2021-03-31 262.7
HF Sarissa Capital Master Fund II LP [2021-03-31] 9.0 9.8
HF Sarissa Capital Athena Fund Ltd 2020-03-30 59.4
HF Sarissa Capital Hawkeye Fund LP 2020-03-30 95.3
HF Sarissa Capital Catapult Fund LLC [2018-03-29] 132.3 126.9
HF Sarissa Capital Domestic Fund LP [2013-04-02] 351.7 321.5
HF Sarissa Capital Offshore Master Fund LP [2013-04-02] 351.7 89.6
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 9 550.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 1 8.6
Total 10 558.6
By Discretionary
Discretionary 10 558.6
Non-Discretionary 0 0.0
Total 10 558.6
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 558.6
Total 10 558.6
Form D Directors # Filings # Firms 2011 - 2025
Alexander Denner 6
Sarissa Capital Fund GP LP 1
Mark Dipaolo 1
Patrice Bonfiglio 1
EDGAR Form CIK 2011 - 2025
13F-HR [0001577524]
3 [0001577524]
4 [0001577524]
SC 13D [0001577524]
SC 13G [0001577524]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sarissa Capital Management LP Amarin Corp PLC UK [2022-01-24]
Sarissa Capital Management LP Alkermes PLC [2021-05-10]
Sarissa Capital Management LP Mersana Therapeutics Inc [2021-01-25]
Sarissa Capital Management LP Biocryst Pharmaceuticals Inc [2021-01-25]
Sarissa Capital Management LP Iterum Therapeutics PLC [2020-11-23]
Sarissa Capital Management LP Medicines Co /DE [2019-05-30]
Sarissa Capital Management LP Regulus Therapeutics Inc [2019-05-17]
Sarissa Capital Management LP Ironwood Pharmaceuticals Inc [2019-05-16]
Sarissa Capital Management LP Mersana Therapeutics Inc [2019-03-11]
Sarissa Capital Management LP Innoviva Inc [2019-02-25]
View All
Form 3/4/5 Subject 2011 - 2025
Sarissa Capital Management LP
Denner Alexander J
Ironwood Pharmaceuticals Inc
Innoviva, Inc.
Sarissa Capital Master Fund II LP
Sarissa Capital Offshore Master Fund LP
Sarissa Capital Hawkeye Fund LP
Iterum Therapeutics plc
Sarissa Capital Catapult Fund LLC
Sarissa Capital Acquisition Corp.
View All
Comparable Firms State AUM ($B)
Western Standard LLC
CA 0.6
Stieven Capital Advisors LP
MO 0.6
Alta Fox Capital Management LLC
TX 0.6
Borealis Strategic Capital Partners LP
IL 0.6
Ikarian Capital LLC
TX 0.6
Alight Capital Management LP
NY 0.6
Stanley Capital Management LLC
TX 0.6
Diametric Capital LP
MA 0.6
NAVI Intl-Administradora E Gestora de Recursos Financeiros LTDA
0.6
Collab Currency Management LLC
0.6
Terms | Privacy | Guide
tony@aum13f.com